BriaCell Therapeutics (BCTX) Research & Development (2021 - 2026)
BriaCell Therapeutics' Research & Development was $5.97 million in fiscal Q3 2026 (quarter ended Apr 30, 2026), up 24.0% from $4.81 million a year earlier but down 1.4% from the prior quarter.
BriaCell Therapeutics (BCTX) Research & Development (2021 - 2026) Analysis & Trends
On a trailing twelve-month basis, BriaCell Therapeutics' Research & Development was $25.81 million through Apr 30, 2026, up 39.0% year-over-year; for FY2025 (ended Jul 31, 2025), it was $21.27 million, down 21.7% from FY2024.
- Research & Development shows a five-year compound annual growth rate of 54.4% (FY2020 to FY2025).
- In earlier fiscal years, Research & Development was $27.18 million in FY2024 (+77.2%), $15.34 million in FY2023 (+91.2%), $8.02 million in FY2022 (+296.9%) and $2.02 million in FY2021 (-16.7%).
- Quarterly Research & Development has moved between $580,819 (fiscal Q4 2021) and $8.26 million (fiscal Q2 2024) over five years.
- Compared with a year earlier, Research & Development has increased for four straight quarters, with growth averaging 5.6% over the last eight quarters.
- The best year-over-year quarter for Research & Development over five years was fiscal Q2 2022 (growth of 931.6%); the worst was fiscal Q1 2025 (a decline of 46.5%).
- Per Business Quant data, BCTX's Research & Development in the three fiscal quarters before Q3 2026 was $6.05 million (Q2 2026), $6.68 million (Q1 2026) and $7.11 million (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 993.80 Mn |
| 10 | BriaCell Therapeutics | 30.16 Mn | 29.51 Mn | - | 5.97 Mn |
Historic Data
| Date | Value |
|---|---|
| Apr 30, 2026 | 5.97 Mn |
| Jan 31, 2026 | 6.05 Mn |
| Oct 31, 2025 | 6.68 Mn |
| Jul 31, 2025 | 7.11 Mn |
| Apr 30, 2025 | 4.81 Mn |
| Jan 31, 2025 | 5.68 Mn |
| Oct 31, 2024 | 3.67 Mn |
| Jul 31, 2024 | 4.41 Mn |
| Apr 30, 2024 | 7.66 Mn |
| Jan 31, 2024 | 8.26 Mn |
| Oct 31, 2023 | 6.86 Mn |
| Jul 31, 2023 | 5.17 Mn |
| Apr 30, 2023 | 3.86 Mn |
| Jan 31, 2023 | 3.05 Mn |
| Oct 31, 2022 | 3.26 Mn |
| Jul 31, 2022 | 3.17 Mn |
| Apr 30, 2022 | 2.27 Mn |
| Jan 31, 2022 | 1.71 Mn |
| Oct 31, 2021 | 875,636.00 |
| Jul 31, 2021 | 580,819.00 |
BriaCell Therapeutics Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=BCTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "BCTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=BCTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();